Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice N. F. SmithA. HayesP. Workman Original Article 29 July 2004 Pages: 475 - 486
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors Laura L. JungRamesh K. RamanathanWilliam C. Zamboni Original Article 18 August 2004 Pages: 487 - 496
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A V. SamouëlianC. M. MaugardA.-M. Mes-Masson Original Article 16 July 2004 Pages: 497 - 504
Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro Yasuhiko KanoMiyuki AkutsuYusuke Furukawa Original Article 31 August 2004 Pages: 505 - 513
Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study Klaus MrossBernward NiemannChristine E. Swenson Original Article 21 August 2004 Pages: 514 - 524
Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract Pornngarm LimtrakulOrawan KhantamatKomsak Pintha Original Article 10 July 2004 Pages: 525 - 530
Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer Takashi TsujiTerumitsu SawaiYutaka Tagawa Original Article 10 August 2004 Pages: 531 - 536
Synergistic killing of human leukemia cells by antioxidants and trichostatin A Jiuhong KangJie ChenYingxian Ou Original Article 10 July 2004 Pages: 537 - 545
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer E. EspinosaS. MoralesM. González Barón Original Article 17 August 2004 Pages: 546 - 552
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases Olatoyosi M. OdenikeRonald M. SobecksRichard A. Larson Original Article 02 September 2004 Pages: 553 - 561
A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells Sei-Jung LeePhil-Sun OhKye-Taek Lim Original Article 02 September 2004 Pages: 562 - 572
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer Minoru FukudaMikio OkaThe Nagasaki Thoracic Oncology Group Original Article 10 September 2004 Pages: 573 - 577